MAP2K1 and myocardial ischemia: In a myocardial ischemia-reperfusion model, the activation of ERK1/2 has been found to reduce apoptosis caused by reperfusion injury, indicating that the MAP2K1 signaling pathway may provide cardioprotective effects (26).